Upregulation of p21, a central player in the regulation of cell cycle, has been involved in the G2/M arrest of various cancer cells induced by diverse anticancer agents including active bufadienolide compounds (12, 14, 22, 24, 43). Here, CDKN1A is linked to cancer.